Mylan, Perrigo Settle Suit After $27B Hostile Takeover Row
Mylan and fellow generic-drug maker Perrigo told a New York federal court Friday they had settled a suit in which Mylan was accused of misleading Perrigo investors in a failed $27...To view the full article, register now.
Already a subscriber? Click here to view full article